Therapure Signs Manufacturing Deal With VBI Vaccines for COVID-19 Vaccine Candidates

Ontario Industry Updates
Written By Guest User
therapure-biopharma_owler_20190911_042124_original.jpg

Therapure Biomanufacturing announced the signing of an agreement with VBI Vaccines Inc. for the manufacture of their coronavirus vaccine candidates. Under this agreement, Therapure will be responsible for the biomanufacturing of the vaccine drug substance as well as the aseptic fill of the drug product at the Therapure facility in Mississauga, Ontario.

Guest User
Previous

Green Shield Canada Partners with Mobio Interactive

Next

7D Surgical Receives HSA Approval in Singapore and Achieves First Unit Sales in Southeast Asia